Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot179410.32687/0869-866X-2024-32-s2-1170-1175Научная статьяEPIDEMIOLGY OF DUCHENNE MUSCULAR DYSTROPHY IN THE RUSSIAN FEDERATIONSterlikovS. A.ZelenovaO. V.StarodubovV. I.VitkovskayaI. P.AbramovS. I.OskovYu. I.KucheryavayaD. A.GolubevN. A.KamyninaN. N.Central Research Institute of Healthcare Organization and Informatization, 127254, Moscow, RussiaA. V. Vishnevsky National Medical Research Center for Surgery, 117997, Moscow, RussiaMorozovskaya Children's City Clinical Hospital, 119049, Moscow, RussiaRussian National Research Medical University named after N. I. Pirogov, 117513, Moscow, RussiaResearch Institute of Health Care Organization and Medical Management, 115088, Moscow, Russia08112024321170117502072025Copyright © 1970,1970Knowledge of the epidemiology of Duchenne muscular dystrophy is advisable for planning measures to improve the diagnosis and treatment of this disease. Purpose: to study the epidemic situation of Duchenne muscular dystrophy, as well as the average age of its diagnosis in the Russian Federation. The problem of accuracy of statistical estimates is due to heterogeneous diagnostic criteria. The development of unified diagnostic criteria (male gender and mutation carrier) is required. It is advisable to consider the issue of screening the level of creatine phosphokinase in young children with subsequent targeted examination of children with high levels, including testing for carriage of the Duchenne muscular dystrophy mutation.Duchenne muscular dystrophyincidence of Duchenne muscular dystrophy, prevalence of Duchenne muscular dystrophy, incidence of Duchenne muscular dystrophy at birth.миодистрофия Дюшенназаболеваемость миодистрофией Дюшенна, распространённость миодистрофии Дюшенна, частота миодистрофии Дюшенна при рождении[Прогрессирующая мышечная дистрофия Дюшенна. Прогрессирующая мышечная дистрофия Беккера. Клинические рекомендации. G71.0. Дети. М.; 2023. С. 98.][Ishizaki M., Kobayashi M., Adachi K. et al. Female dystrophinopathy: review of current literature // Neuromuscul. Disord. 2018. Vol. 28, N 7. С. 572—581. DOI: 10.1016/j.nmd.2018.05.002][Lee I., Turnage C., Sutyla R. et al. The hidden disease: delayed diagnosis in Duchenne muscular dystrophy and co-occurring conditions // J. Dev. Behav. Pediatr. 2022. Vol. 43, N 8. P. e541-e545. DOI: 10.1097/dbp.0000000000000948][Гайнетдинова Д. Д., Новоселова А. А. Современные возможности диагностики и лечения мышечной дистрофии Дюшенна // Казанский медицинский журнал. 2020. Т. 101, №4. С. 530—537.][Mohamed K., Appleton R., Nicolaides P. Delayed diagnosis of Duchenne muscular dystrophy // Eur. J. Paediatr. Neurol. 2000. Vol. 4, N 5. P. 219—223. DOI: 10.1054/ejpn.2000.0274][McMillan H. J., Gregas M., Darras B. T., Kang P. B. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy // Pediatrics. 2011. Vol. 127, N 1. P. e132—e136. DOI: 10.1542/peds.2010-0922][Mah J. K., Korngut L., Dykeman J. et al. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy // Neuromuscul. Disord. 2014. Vol. 24, N 6. P. 482—491. DOI: 10.1016/j.nmd.2014.03.001][Theadom A., Rodrigues M., Roxburgh R. et al. Prevalence of muscular dystrophies: a systematic literature review // Neuroepidemiology. 2014. Vol. 43, N 3-4. P. 259—268. DOI: 10.1159/000362899][Crisafulli S., Sultana J., Fontana A. et al. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis // Orphanet. J. Rare Dis. 2020. Vol. 15, N 1. P. 141. DOI: 10.1186/s13023-020-01302-7][Mccaffrey T., Guglieri M., Murphy A. P. et al. Cardiac involvement in female carriers of duchenne or becker muscular dystrophy // Muscle Nerve. 2017. Vol. 55, N 6. P. 810—818. DOI: 10.1002/mus.25555][Царькова С. А., Ушакова Р. А., Громада Н. Е. и др. Прогрессирующая мышечная дистрофия Дюшенна—Беккера. Трудности диагностики // Доктор.Ру. 2020. Т. 19, №10. С. 61—65.][D’Amico A., Catteruccia M., Baranello G. et al. Diagnosis of Duchenne muscular dystrophy in Italy in the last decade: critical issues and areas for improvements // Neuromusc. Dis. 2017. Vol. 27. P. 447—451. DOI: 10.1016/j.nmd.2017.01.007][Nadarajah V. D., van Putten M., Chaouch A. et al. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD) // Neuromusc. Dis. 2011. Vol. 21, N 8. P. 569—578. DOI: 10.1016/j.nmd.2011.05.006][Рекомендации по ведению пациентов с миодистрофией Дюшенна. 2-е издание. М.; 2018. С. 63.][Salari N., Fatahi B., Valipour E. et al. Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis // J. Orthop. Surg. Res. 2022. Vol. 17, N 1. P. 96. DOI: 10.1186/s13018-022-02730-4][Ryder S., Leadley R. M., Armstrong N. et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review // Orphanet. J. Rare Dis. 2017. Vol. 12, N 1. P. 79. DOI: 10.1186/s13023-017-0665-2]